We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$347B
AUM Growth
+$49B
Cap. Flow
+$12.7B
Cap. Flow %
3.67%
Top 10 Hldgs %
25.82%
Holding
11,328
New
1,232
Increased
3,827
Reduced
4,449
Closed
1,709

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$1.33B
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$781M
3
TSLA icon
Tesla
TSLA
+$468M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$467M
5
HD icon
Home Depot
HD
+$344M

Sector Composition

Rank Sector Weight
1 Technology 2.2%
2 Consumer Discretionary 1.94%
3 Communication Services 1.89%
4 Healthcare 1.12%
5 Financials 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COMG
11151
DELISTED
GraniteShares S&P GSCI Commodity Broad Strategy No K-1 ETF
COMG
-28,360
Closed -$595K
TMCXW
11152
DELISTED
Trinity Merger Corp. Warrant
TMCXW
-27,603
Closed -$35K
DOVA
11153
CALL
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
-148,600
Closed -$4.15M
DOVA
11154
PUT
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
-45,000
Closed -$1.26M
DEMG
11155
DELISTED
Xtrackers FTSE Emerging Comprehensive Factor ETF
DEMG
-10,803
Closed -$249K
DF
11156
CALL
DELISTED
Dean Foods Company
DF
-107,500
Closed -$125K
DF
11157
DELISTED
Dean Foods Company
DF
-99,370
Closed -$115K
DF
11158
PUT
DELISTED
Dean Foods Company
DF
-256,400
Closed -$297K
DESC
11159
DELISTED
Xtrackers Russell 2000 Comprehensive Factor ETF
DESC
-11,112
Closed -$370K
GHDX
11160
CALL
DELISTED
Genomic Health, Inc.
GHDX
-8,000
Closed -$543K
GHDX
11161
DELISTED
Genomic Health, Inc.
GHDX
-40,472
Closed -$2.75M
GHDX
11162
PUT
DELISTED
Genomic Health, Inc.
GHDX
-44,500
Closed -$3.02M
SKYS
11163
DELISTED
Sky Solar Holdings, Ltd.
SKYS
-5,137
Closed -$6K
RVEN
11164
DELISTED
Reven Housing REIT, Inc.
RVEN
-16,094
Closed -$82K
BPL
11165
CALL
DELISTED
Buckeye Partners, L.P.
BPL
-9,500
Closed -$390K
BPL
11166
DELISTED
Buckeye Partners, L.P.
BPL
-614,482
Closed -$25.2M
BPL
11167
PUT
DELISTED
Buckeye Partners, L.P.
BPL
-215,500
Closed -$8.86M
LTXB
11168
DELISTED
LegacyTexas Financial Group Inc
LTXB
-22,311
Closed -$971K
UBNK
11169
DELISTED
United Financial Bancorp, Inc.
UBNK
-111,710
Closed -$1.52M
CJ
11170
DELISTED
C&J Energy Services, Inc.
CJ
-46,152
Closed -$495K
OTIV
11171
DELISTED
OTI On Track Innovations Ltd
OTIV
-51,676
Closed -$17K
CVRS
11172
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
-42,967
Closed -$184K
MDSO
11173
CALL
DELISTED
Medidata Solutions, Inc.
MDSO
-72,400
Closed -$6.63M
MDSO
11174
PUT
DELISTED
Medidata Solutions, Inc.
MDSO
-7,500
Closed -$686K
WBIB
11175
DELISTED
WBI BullBear Value 2000 ETF
WBIB
-11,921
Closed -$263K

Similar funds

Jeff Yass's Q4 2019 Portfolio in Review

As of Q4 2019, Jeff Yass held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass deployed $12.7B of net new capital in Q4 2019, opening 1,232 new positions and adding to 3,827 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Amazon, an estimated $1.36B trimmed.

  • Jeff Yass's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
  • Jeff Yass added most to Boeing in Q4 2019, an estimated $1.33B increase.
  • Jeff Yass's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
  • Jeff Yass fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
  • Jeff Yass's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
  • Jeff Yass opened 1,232 new positions and closed 1,709 in Q4 2019.
  • Jeff Yass's portfolio value rose 16% quarter-over-quarter to $347B.

Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.